Supporting the health and care system in improving productivity | What we do | About | NICE

Privacy notice | NICE

Accessibility | NICE

Life sciences: how to get your product to market | What we do | About | NICE

Cookies | About | NICE

Press and media | News | NICE

NHS at 75 | Blogs | News | NICE

Reusing our content | NICE

Board | Who we are | About | NICE

Overview | Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer | Guidance | NICE

All interactive components on a page, such as buttons or menus, should be far enough apart 
from other interactive areas, to avoid them being used by mistake. 

This ensures people with motor impairments can easily click or tap on the right element.

## Methodology

This check is run on both the mobile and desktop versions of every page. Results
for each may differ.

1. All interactive elements are identified, including buttons, links, and form controls.
2. If an element is not normally visible, it is ignored. This includes elements which
   are positioned offscreen or cropped (e.g. for 'screen-reader only' text).
3. If an element is larger than 24 CSS pixels in both dimensions, it passes.
4. Otherwise, the element is compared to all other elements on the page.
5. The minimum horizontal gap between the element is calculated as 24 CSS pixels,  
   minus the width of the element.
6. The minimum vertical gap between the element is calculated as 24 CSS pixels,  
   minus the height of the element.
7. If another element falls within the minimum horizontal or vertical gap, the 
   element fails, unless both are links that point to the same place.

## Further reading

This is part of the draft WCAG 2.2 specification and is subject to change.

* [Target Size (Minimum)](https://w3c.github.io/wcag/understanding/target-size-minimum.html)

ensure-minimum-target-size

May 2024

April 2024

National Institute for Clincial Excellence

Title / URL	Issues
Supporting the health and care system in improving productivity \| What we do \| About \| NICEwww.nice.org.uk/productivity	68
Privacy notice \| NICEwww.nice.org.uk/privacy-notice	60
Accessibility \| NICEwww.nice.org.uk/accessibility	22
Life sciences: how to get your product to market \| What we do \| About \| NICEwww.nice.org.uk/about/what-we-do/life-sciences	14
Cookies \| About \| NICEwww.nice.org.uk/cookies	14
Press and media \| News \| NICEwww.nice.org.uk/news/press-and-media	12
NHS at 75 \| Blogs \| News \| NICEwww.nice.org.uk/news/blog/nhs-at-75	9
Reusing our content \| NICEwww.nice.org.uk/re-using-our-content	8
Board \| Who we are \| About \| NICEwww.nice.org.uk/about/who-we-are/board	6
Overview \| Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer \| Guidance \| NICEwww.nice.org.uk/guidance/ta898	6

Ensure interactive components are far enough apart

National Institute for Clincial Excellence

Where this issue has occurred